PTAC/CFTR
Kara Foshay, PhD
Cystic Fibrosis Foundation
Deepika Polineni, MD, MPH
Washington University in St. Louis
JP Clancy
Clinical Research
Cystic Fibrosis Foundation
This session will delineate preclinical studies directed towards evaluating nucleotide-based therapeutics. In vitro model systems and development of an assay matrix, small and large animal models (including non-human primates), and key biomarkers for proof-of-concept in human studies will be critically reviewed.
Speaker: Kara Foshay, PhD – Cystic Fibrosis Foundation
Speaker: Wanda K. O'Neal, PhD – University of North Carolina at Chapel Hill
Speaker: John F. Engelhardt, PhD – The University of Iowa
Speaker: Deepika Polineni, MD, MPH – Washington University in St. Louis